- Home
- IMCR vs KLIC Comparison
IMCR vs KLIC Comparison
Compare IMCR & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- KLIC
- Stock Information
- Founded
- IMCR 2008
- KLIC 1951
- Country
- IMCR United Kingdom
- KLIC United States
- Employees
- IMCR N/A
- KLIC N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- KLIC Semiconductors
- Sector
- IMCR Health Care
- KLIC Technology
- Exchange
- IMCR Nasdaq
- KLIC Nasdaq
- Market Cap
- IMCR 1.7B
- KLIC 1.7B
- IPO Year
- IMCR 2021
- KLIC N/A
- Fundamental
- Price
- IMCR $35.17
- KLIC $34.00
- Analyst Decision
- IMCR Buy
- KLIC Strong Buy
- Analyst Count
- IMCR 10
- KLIC 4
- Target Price
- IMCR $58.13
- KLIC $48.00
- AVG Volume (30 Days)
- IMCR 250.5K
- KLIC 430.1K
- Earning Date
- IMCR 08-07-2025
- KLIC 08-06-2025
- Dividend Yield
- IMCR N/A
- KLIC 2.42%
- EPS Growth
- IMCR N/A
- KLIC N/A
- EPS
- IMCR N/A
- KLIC 0.40
- Revenue
- IMCR $333,581,000.00
- KLIC $691,079,000.00
- Revenue This Year
- IMCR $26.82
- KLIC N/A
- Revenue Next Year
- IMCR $8.15
- KLIC $16.25
- P/E Ratio
- IMCR N/A
- KLIC $85.55
- Revenue Growth
- IMCR 25.75
- KLIC N/A
- 52 Week Low
- IMCR $23.15
- KLIC $26.63
- 52 Week High
- IMCR $40.88
- KLIC $52.08
- Technical
- Relative Strength Index (RSI)
- IMCR 53.52
- KLIC 42.09
- Support Level
- IMCR $32.20
- KLIC $34.31
- Resistance Level
- IMCR $37.63
- KLIC $36.36
- Average True Range (ATR)
- IMCR 1.21
- KLIC 1.02
- MACD
- IMCR 0.03
- KLIC -0.31
- Stochastic Oscillator
- IMCR 53.90
- KLIC 10.66
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.